NHS scientists have developed an innovative drug for patients with incurable forms of cancer.
Medicines called "Enterrectinib" belong to anticancer drugs and are able to treat various types of diseases, regardless of their location in the body.
This drug differs from traditional methods of treatment, which are based on the location of the tumor. "Enterrectinib" becomes the second such drug that received the "green light".
It said the drug is intended for people 12 years of age and older who are dealing with rare forms of cancer known as NTRK fusions.
"Treatments such as Enterrectinib could revolutionize the way cancer is treated by targeting genetic mutations that activate tumor growth, regardless of its location," NHS scientist Meindert Boise said.
